# THALIDOMIDE
> **ANDA213267** · Abbreviated New Drug Application (Generic) · Sponsor: NATCO · Approved 2023-04-27
## Drug
- **FDA Application Number:** ANDA213267
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** THALIDOMIDE
- **Generic name:** Thalidomide
- **Active ingredients:** THALIDOMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NATCO
- **First approval:** 2023-04-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213267)
---
*MORVS · CC0 1.0*